Q3 net sales reach KRW97.5 billion amid U.S. sales model changes, as the company builds a foundation for mid- to long-term growth Q3 combined net sales of botulinum toxin, HA fillers, and skinboosters surge 54% in Korea and 18% in Europe and other regions, year-on-year Strong performance...